✦ LIBER ✦

A phase II study of a 3-day schedule with topotecan and cisplatin every three weeks in patients with previously intreated small cell lung cancer and extensive disease

✍ Scribed by Lassen, Ulrik N.; Sorensen, Morten; Jensen, Peter Buhl; Langer, Seppo W.; Jensen, Britta Bjerregaard; Jeppesen, Nina; Rytter, Carsten; Mellemgaard, Anders; Hansen, Olfred; Osterlind, Kell

Book ID: 118572252
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 190 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)92524-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised Phase II study of topotecan/c

Randomised Phase II study of topotecan/cisplatin versus topotecan/etoposide in patients with untreated, extensive disease, small cell lung cancer (SCLC)

✍ Gervais, R; Quoix, E; Mattson, K; Schramel, F.M; Rivière, A; Fields, S; Wheatley 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

A phase I study of 3-day topotecan and c

A phase I study of 3-day topotecan and cisplatin in elderly patients with small-cell lung cancer

✍ Keiichi Fujiwara; Hiroshi Ueoka; Katsuyuki Kiura; Masahiro Tabata; Nagio Takigaw 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 198 KB

Irinotecan and cisplatin with concurrent

Irinotecan and cisplatin with concurrent thoracic radiotherapy in a once-every-three-weeks schedule in patients with limited-disease small-cell lung cancer: A phase I study

✍ de Jong, W.K.; de Jonge, M.J.A.; van der Leest, A.H.D.; van Meerbeeck, J.P.; Gro 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Randomized, phase II study of topotecan/

Randomized, phase II study of topotecan/paclitaxel versus cisplatin/etoposide in patients with untreated, extensive disease, small cell lung cancer (SCLC)

✍ H. Lena; J. Breton; W. Yu; K. Steppert; K. Lightcap; G. Ross; M. Lymboura 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Randomised phase II trial of irinotecan

Randomised phase II trial of irinotecan plus cisplatin vs irinotecan, cisplatin plus etoposide repeated every 3 weeks in patients with extensive-disease small-cell lung cancer

✍ Sekine, I; Nokihara, H; Takeda, K; Nishiwaki, Y; Nakagawa, K; Isobe, H; Mori, K; 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 108 KB

A phase II study of biweekly irinotecan

A phase II study of biweekly irinotecan and cisplatin for patients with extensive stage disease small cell lung cancer

✍ Bae, Sung Hwa; Ryoo, Hun Mo; Do, Young Rok; Song, Hong Suk; Kwon, Ki Young; Kim, 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 176 KB